Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2011 Dec;86(12):998-1000.
doi: 10.1002/ajh.22168. Epub 2011 Oct 17.

Elevated serum free light chains are associated with inferior event free and overall survival in Hodgkin lymphoma

Carrie A Thompson  1 , Matthew J Maurer, James R Cerhan, Jerry A Katzmann, Stephen M Ansell, Thomas M Habermann, William R Macon, George J Weiner, Brian K Link, Thomas E Witzig
Affiliations
Multicenter Study

Elevated serum free light chains are associated with inferior event free and overall survival in Hodgkin lymphoma

Carrie A Thompson et al. Am J Hematol. 2011 Dec.

Abstract

The serum free light chain (FLC) assay quantitates free immunoglobulin kappa and lambda light chains, which has prognostic value in plasma cell dyscrasias. However, there is limited data on serum FLC in lymphoid malignancies. We analyzed the association of pretreatment FLC with event-free survival (EFS) and overall survival (OS) in 100 patients with Hodgkin lymphoma (HL). Elevated polyclonal FLC were present in 30% of patients; these patients had an inferior EFS (HR = 4.84; 95% CI: 1.84-12.7) and OS (HR = 8.87; 95% CI: 2.35-33.52) compared to patients with normal FLC. Further studies of FLC in HL are warranted.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: Nothing to report

Figures

Figure 1
Figure 1
Kaplan Meier curves for event-free (A) and overall survival (B). Hazard ratios are unadjusted Cox models and Cox model adjusted for International Prognostic Score. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
See this image and copyright information in PMC

References

    1. Bradwell AR, Carr-Smith HD, Mead GP, et al. Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. Clin Chem. 2001;47:673–680. - PubMed
    1. Katzmann JA, Abraham RS, Dispenzieri A, et al. Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice. Clin Chem. 2005;51:878–881. - PubMed
    1. Rajkumar SV, Kyle RA, Therneau TM, et al. Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. Blood. 2005;106:812–817. - PMC - PubMed
    1. Dingli D, Kyle RA, Rajkumar SV, et al. Immunoglobulin free light chains and solitary plasmacytoma of bone. Blood. 2006;108:1979–1983. - PMC - PubMed
    1. Abraham RS, Katzmann JA, Clark RJ, et al. Quantitative analysis of serum free light chains. A new marker for the diagnostic evaluation of primary systemic amyloidosis. Am J Clin Pathol. 2003;119:274–278. - PubMed

Publication types

Substances